Document is current
Any future updates will be listed below
-
Authors
Beslot, Auxane
Grall-Bronnec, Marie
Balem, Marianne
Schreck, Benoit
Laforgue, Edouard-Jules
Victorri-Vigneau, Caroline
Guillou-Landreat, Morgane
Leboucher, Juliette
,
Bodenez, Pierre
Grall-Bronnec, Marie
Guillou-Landréat, Morgane
Le Geay, Bertrand
Martineau, Isabelle
Levassor, Philippe
Bolo, Paul
Guillet, Jean-Yves
Guillery, Xavier
Dano, Corine
Challet-Bouju, Gaëlle
Cabelguen, Clémence
-
Funding
Funding for this research was provided by:
French Inter-ministerial Mission for Combating Drugs and Addictive Behaviours (MILDECA) and Université Paris 13 (PREVDROG)
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 17 August 2024
First Online: 9 September 2024
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. The OPAL study was approved by the local ethics committee. The participants were informed about this study, and their written consent was systematically collected.
: Not applicable.
: The authors declare no competing interests.
